- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
38 result(s) found for: Digestive tube.
Displaying page 1 of 2.
EudraCT Number: 2018-003680-62 | Sponsor Protocol Number: CHIPPI-1808 | Start Date*: 2019-02-06 | |||||||||||||||||||||
Sponsor Name:Centre Oscar Lambret | |||||||||||||||||||||||
Full Title: Phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer considering two different settings: Primary Debulking Surgery (PDS) and Interval D... | |||||||||||||||||||||||
Medical condition: Epithelial ovarian cancer, Fallopian tube ovarian cancer, Peritoneal ovarian cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) BE (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002349-38 | Sponsor Protocol Number: 2-54-52030-156 | Start Date*: 2007-02-26 |
Sponsor Name:Beaufour Ipsen Pharma-Ipsen Biotech Department | ||
Full Title: Phase III multicentre, Randomised, Double Blind, Comparative study to assess the efficacy and safety of lanreotide 30mg versus placebo as a palliative treatment of clinical symptoms associated with... | ||
Medical condition: Patient having a high digestive obstruction of malignant origin i.e. located on the upper part of the gastro-intestinal tract (stomach, duodenum, small bowel) for whom surgery is inappropriate. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000087-26 | Sponsor Protocol Number: 2019/09 | Start Date*: 2020-04-16 | |||||||||||||||||||||
Sponsor Name:CMC AMBROISE PARE | |||||||||||||||||||||||
Full Title: Time to transit Recovery After treatment with Naloxegol in cardiac Surgery Intensive care Trial | |||||||||||||||||||||||
Medical condition: ileus after cardiac surgery | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-001054-17 | Sponsor Protocol Number: PHRN15-SE/AMIKINHAL | Start Date*: 2017-01-27 | |||||||||||
Sponsor Name:CHRU de Tours | |||||||||||||
Full Title: Double-blinded multicenter randomized controlled trial comparing inhaled amikacin versus placebo to prevent ventilator associated pneumonia | |||||||||||||
Medical condition: Patient with mechanical ventilation through an endotracheal tube | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003206-41 | Sponsor Protocol Number: TAK-954-2002 | Start Date*: 2018-05-29 | |||||||||||
Sponsor Name:Millennium Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2b, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous TAK-954 in Critically Ill Patients With Enteral Feeding Int... | |||||||||||||
Medical condition: A Phase 2b, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous TAK-954 in Critically Ill Patients With Enteral Feeding Int... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002174-43 | Sponsor Protocol Number: A-48-52030-269 | Start Date*: 2014-03-27 | |||||||||||
Sponsor Name:IPSEN NV | |||||||||||||
Full Title: AN INTERNATIONAL, MULTICENTRIC, PROSPECTIVE, OPEN LABEL STUDY TO ASSESS THE EFFICACY AND SAFETY OF LANREOTIDE AUTOGEL 120 MG ASSOCIATED TO STANDARD OF CARE IN THE TREATMENT OF CLINICAL SYMPTOMS AS... | |||||||||||||
Medical condition: Inoperable malignant intestinal obstruction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001374-29 | Sponsor Protocol Number: 1 | Start Date*: 2012-11-30 | |||||||||||
Sponsor Name:North Bristol NHS Trust | |||||||||||||
Full Title: Delivering adequate nutrition to critically ill patients suffering delayed gastric emptying: RCT of nasointestinal feeding versus nasogastric feeding plus prokinetics. | |||||||||||||
Medical condition: Delayed gastric emptying, refractory to 24h of metoclopramide treatment in mechanically ventilated patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005753-12 | Sponsor Protocol Number: RG_15-026 | Start Date*: 2017-11-22 |
Sponsor Name:University of Birmingham | ||
Full Title: Prospective, open-label, randomised pilot study to assess two possible routes of Faecal Microbiota Transplant (FMT) delivery in patients with ulcerative colitis. | ||
Medical condition: Ulcerative colitis for at least 3 months prior to trial entry | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000184-24 | Sponsor Protocol Number: EC11-222 | Start Date*: Information not available in EudraCT |
Sponsor Name:ANTONIO JEREZ CALERO | ||
Full Title: Whole body hypothermia + melatonin vs whole body hypothermia + placebo in asphyctic newborns. A multicentric, ramdomized, controlled and double blind clinical trial | ||
Medical condition: Hipothermia plus melatonine neuroprotection terapy in asphixiated newborns. | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004707-67 | Sponsor Protocol Number: 2014-880 | Start Date*: 2016-01-13 | ||||||||||||||||
Sponsor Name:Hospices Civils de Lyon | ||||||||||||||||||
Full Title: REDUCTION BY PASIREOTIDE OF THE EFFLUENT VOLUME IN HIGH-OUTPUT ENTEROSTOMY IN PATIENTS REFRACTORY TO USUAL MEDICAL TREATMENT: PHASE II MULTICENTRIC RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY | ||||||||||||||||||
Medical condition: Patients with high-output ileostomy or jejunostomy and failure of treatment with loperamide +/- codein syrup | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004687-37 | Sponsor Protocol Number: 14SM2335 | Start Date*: 2016-06-17 | |||||||||||
Sponsor Name:Imperial College Healthcare NHS Trust | |||||||||||||
Full Title: Use of Methylnaltrexone for the Treatment of Opioid Induced Constipation & Gastro-Intestinal Stasis in Intensive Care Patients | |||||||||||||
Medical condition: Opioid Induced Constipation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002016-28 | Sponsor Protocol Number: 20040118 | Start Date*: 2005-01-04 | |||||||||||
Sponsor Name:Amgen | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduct... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) AT (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000473-39 | Sponsor Protocol Number: CIR-ILI-2014 | Start Date*: 2015-01-19 | |||||||||||
Sponsor Name:Fundacio Parc TaulĂ | |||||||||||||
Full Title: Randomized and prospective clinical trial about the therapeutic use of diatrizoic acid (Gastrografin®) in postoperative ileus. | |||||||||||||
Medical condition: Postoperative paralytic Ileus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023229-38 | Sponsor Protocol Number: TZP-101-CL-P008 | Start Date*: 2011-04-21 | |||||||||||
Sponsor Name:Tranzyme, Inc | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastroin... | |||||||||||||
Medical condition: post-operative ileus in subjects who have undergone partial bowel resection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) CZ (Completed) ES (Ongoing) BG (Completed) HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003318-42 | Sponsor Protocol Number: TAK-954-2004 | Start Date*: 2019-06-11 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postope... | |||||||||||||
Medical condition: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postope... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023228-26 | Sponsor Protocol Number: TZP-101-CL-P007 | Start Date*: 2011-02-18 | |||||||||||
Sponsor Name:Tranzyme, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastroin... | |||||||||||||
Medical condition: post-operative ileus in subjects who have undergone partial bowel resection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003226-23 | Sponsor Protocol Number: APD334-206 | Start Date*: 2021-02-02 | |||||||||||
Sponsor Name:Arena Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects with Eosinophilic Esophagitis | |||||||||||||
Medical condition: Eosinophilic Esophagitis (EoE) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022758-18 | Sponsor Protocol Number: CNTO1275CRD3001 | Start Date*: 2011-08-24 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severe... | |||||||||||||
Medical condition: Moderately to severely active Crohn's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) GB (Completed) BE (Completed) CZ (Completed) IS (Completed) IE (Completed) ES (Completed) DK (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003602-16 | Sponsor Protocol Number: PM1183-A-014-15 | Start Date*: 2022-02-24 | |||||||||||
Sponsor Name:Pharma Mar S.A. | |||||||||||||
Full Title: Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors. | |||||||||||||
Medical condition: Selected Advanced Solid Tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) IT (Trial now transitioned) DE (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001534-13 | Sponsor Protocol Number: JAN13004-30 | Start Date*: 2015-10-02 | |||||||||||
Sponsor Name:SPHERIUM BIOMED S.L. | |||||||||||||
Full Title: Phase IB-II clinical trial of melatonin oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing chemoradiation. | |||||||||||||
Medical condition: Oral mucositis in patients with head and neck cancer undergoing chemoradiation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
